1. Field of the Invention
The present invention relates to the field of office envelopes. More particularly, the present invention relates to a transparent envelope formed with holes whereby a potentially harmful substance contained in the envelope may be withdrawn therefrom via at least one of the holes without tearing the envelope.
2. Prior Art
Personal messages or those types of correspondence that generally require a relatively high level of privacy, such as a bank statement, are usually sent in a sealed opaque envelope. For some business applications, however, a transparent envelope or package is preferred. For example, recipients of a large quantity of shipped merchandise have to return at times articles that have a defect or that were incorrectly shipped. By sending the merchandise, or its documentation, in a transparent envelope, the recipient would be able to examine and, if necessary, return its contents without having to open the envelope. Also, the clerical staff of a large office would be able to expedite the sorting and processing of incoming mail by examining the nature of the correspondence before opening the envelope.
Recently, attempts have been made by terrorists to cause public panic by disseminating biological agents such as anthrax in high-exposure areas and even via the postal service. These agents can be transmitted person-to-person and have the potential of causing a high rate of mortality. Unsuspecting recipients are liable to receive envelopes containing a powdery biological agent. After opening such an envelope, the recipient undergoes a large risk of exposure to the agent. Similarly explosive agents are also liable to be delivered by terrorists to unsuspected recipients by an envelope or package.
Transparent envelopes are well known. For example, International publication WO9950149 teaches a transparent paper product such as an envelope that comprises at least two transparent or translucent surfaces made integral with each other by means of an adhesive. U.S. Pat. No. 6,098,872 discloses an office envelope formed by articulate folds. When more than one sheet of stock is utilized to form the envelope, a transparent sheet may be utilized. US Patent Application 2001/0022317 discloses a flat transparent envelope whose cover sheet and backsheet may be formed of a magnifying material. These publications suffer from the drawback that a potentially harmful substance retained therein may not be withdrawn for inspection without having to tear the envelope.
No speedy and cost-effective means is known, that can be made easily available to the general public, for visually inspecting and withdrawing a portion of the contents of an envelope containing a potentially harmful substance for inspection, without having to tear the envelope.
It is an object of the present invention to provide a transparent envelope.
It is an additional object of the present invention to provide an envelope in which a portion of the contents may be speedily and cost-effectively withdrawn, to allow for the inspection of a potentially harmful substance contained therein.
It is a further object of the present invention to provide an envelope in which a portion of the contents may be withdrawn without having to tear the envelope.
It is a further object of the present invention to provide a method for preventing a potentially harmful substance contained within an envelope from harming bystanders.
Other objects and advantages of the invention will become apparent as the description proceeds.
The present invention relates to an envelope formed from a transparent sheet, the edges of said envelope formed with holes whereby a potentially harmful substance contained in said envelope may be withdrawn therefrom via at least one of said holes without tearing said envelope.
The envelope preferably further comprises a front panel, a rear panel, a top flap and side flaps cut from a transparent sheet, each side flap being interspersed between and sealed to the front and rear panels, the top flap capable of being affixed to said rear panel. The envelope is preferably cut and folded from a single sheet.
The holes are preferably formed along the entire periphery of the envelope.
Each hole preferably has a maximum length of 100 mm and ranges from 1 to 100 mm. The spacing between each hole ranges from 1 to 100 mm.
The term “envelope” as referred to herein indicates an external material encompassing a flat or three-dimensional object or objects.
In one preferred embodiment, the envelope is affixed to an opaque protective covering, which is preferably made of paper, the envelope being affixed to an inside face of the protective covering in such a way that the contents of the envelope is not visible upon the folding of said protective covering.
In this embodiment, the rear panel of the envelope preferably faces the inner side of a section of the protective covering, to allow for the opening and closing of the top flap of the envelope. The envelope is preferably releasably affixed to the protective covering. Furthermore, two complementary sections of the protective covering are preferably affixed to each other. The protective covering is preferably provided with a tamper evident design.
The present invention also relates to a method for preventing a potentially harmful substance contained within an envelope from harming bystanders.
In one aspect, the method comprises providing a transparent envelope formed with holes along its periphery, visually detecting a potentially harmful substance in said envelope, applying a vacuum to the inside of the envelope, whereby the potentially harmful substance contained therein is discharged through the holes into a sealable enclosure for inspection and testing, and discarding said envelope together with its contents if the test reveals that the substance is harmful.
The vacuum is preferably applied by means of a vacuum pump which is positioned along each edge of the envelope, whereby the potentially harmful substance is directed into a corresponding discharge conduit, from which it is directed to the sealable enclosure for inspection and testing.
The step of visually detecting a potentially harmful substance may be performed by optically scanning the envelope with intense light, whereby to view minute particles.
In another aspect, the method comprises providing a transparent envelope, visually detecting a potentially harmful substance in said envelope, and irradiating said envelope with radiation whereby to kill any possible pathogens found within the envelope.
The type of radiation is preferably selected from the group of ultraviolet, Gamma rays, X-rays and ultrasound.
With ultraviolet radiation at a wavelength ranging from 50-1000 nanometers and at a distance of up to 10 cm from the envelope, a suitable range of beam power is 1-1,000,000 microwatts at an energy density of 1 cm2/sec.
When Gamma rays are used, a suitable range of dosage is 5-100 kilograys.
When ultrasonic radiation is used, a suitable speed of wave propagation is 1 Mach at a frequency of at least 1 Hz.
In another aspect, the method comprises providing a mail receptacle, providing a plurality of transparent envelopes within said receptacle, each envelope being formed with holes along its periphery, testing the air quality within said receptacle, whereby the air quality is indicative of the presence of a harmful substance in one of said envelopes disposed within the receptacle, and secluding said plurality of envelopes if the test reveals a presence of a harmful substance in the receptacle.
The testing of air quality is preferably tested by means of a covering secured to the mail receptacle, said covering being provided with at least one flexible hose for the influx or discharge of a gas, each hose being equipped with a valve, whereby to apply to release the gas from the mail receptacle.
The air is preferably allowed to circulate throughout the envelopes contained within the mail receptacle and any potentially hazardous substance is entrained in a stream of gas.
In another aspect, the method comprises providing a mail receptacle, providing a plurality of transparent envelopes within said receptacle, each envelope being formed with holes along its periphery, applying a gas to said plurality of envelopes, allowing said gas to circulate within each of said envelopes, whereby said gas kills any pathogens found in said plurality of envelopes.
Ozone being applied at a mass flow rate of 0.001-100 gm/hr or nitrogen being applied at a mass flow rate of 0.001 gm/m3/hr is suitable for this method.
In the drawings:
Sheet 5, as shown in
Protective covering 25 is preferably provided with a decorative design indicating that a transparent envelope in contained therein, in order to prevent tampering with the envelope. The two complementary sections of protective covering 25 are affixed to each other, e.g. by flap 26, or by any other affixing means. Flap 26 may be releasably affixed, such as by a resealable seal or by a slit formed in one of protective covering sections which is suitable for receiving and securing the flap. The side edges of the protective covering are not sealable, to prevent any surreptitious holding of a potentially harmful substance in any portion of the protective covering. As shown in
Upon detection of a potentially harmful substance within an envelope, some of the following methods may be implemented to prevent harm to bystanders:
Applying a vacuum ranging from 0.001 to 1000 millibar to the inside of the envelope, e.g. by means of a low vacuum pump, whereby the potentially harmful substance contained therein is discharged through the holes into a sealable enclosure for inspection and testing. As shown in
Irradiating the envelope with radiation at a predetermined dosage to thereby kill any possible pathogens found within the envelope. When ultraviolet radiation is used, at a wavelength ranging from 50-1000 nanometers and at a distance of up to 10 cm from the envelope, a suitable range of beam power is 1-1,000,000 microwatts at an energy density of 1 cm2/sec. When Gamma rays are used, a suitable range of dosage is 5-100 kilograys, for all suitable frequencies. When X-rays are used, a suitable beam power is selected which is sufficient for the maximum volume of harmful substance that is to be treated. When ultrasonic radiation is used, a speed of wave propagation of 1 Mach at a frequency of at least 1 Hz is suitable.
Applying a gas to large batches of mail before distribution to thereby kill any possible pathogens found within the envelopes. The application of ozone at a mass flow rate of 0.001-100 gm/hr is sufficient to cause oxidation of and to instantly kill any possible pathogens found within the envelope. The application of nitrogen at a mass flow rate of 0.001 gm/m3/hr is sufficient to prevent the influx of air and consequently to choke any possible pathogens found within the envelope after a predetermined period of time.
Testing the air quality within a mailbox, or any other enclosure containing a multiplicity of envelopes formed with holes. As shown in
This method may be employed to introduce a gas for sanitizing the interior of the mailbox. Furthermore, ozone or nitrogen, with the aforementioned flow rates, may be introduced into the mailbox for treatment of possible pathogens located therein.
Optically scanning each envelope individually. By viewing the contents of an envelope with intense light, minute particles may be seen, which ordinarily would not have been noticed if viewed with normal illumination.
While some embodiments of the invention have been described by way of illustration, it will be apparent that the invention can be carried into practice with many modifications, variations and adaptations, and with the use of numerous equivalents or alternative solutions that are within the scope of persons skilled in the art, without departing from the spirit of the invention or exceeding the scope of the claims.
Number | Date | Country | Kind |
---|---|---|---|
146478 | Nov 2001 | IL | national |
This application is a continuation of International application No. PCT/IL02/00899, filed Nov. 11, 2002, the contents of which are here incorporated by reference in their entirety. Applicant claims the benefit of 35 USC 120.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IL02/00899 | Nov 2002 | US |
Child | 10845617 | May 2004 | US |